Navigation Links
New deep-sea observatory goes live
Date:11/17/2008

Moss Landing, California--Off the coast of Central California, in the inky darkness of the deep sea, a bright orange metal pyramid about the size of two compact cars sits quietly on the seafloor. Nestled within the metal pyramid is the heart of the Monterey Accelerated Research System (MARS)the first deep-sea ocean observatory offshore of the continental United States. Six years and $13.5 million dollars in the making, the MARS Observatory went "live" on Monday, November 10, 2008, returning the first scientific data from 900 meters (3,000 feet) below the ocean surface.

Construction of the observatory was coordinated by the Monterey Bay Aquarium Research Institute (MBARI). According to Marcia McNutt, MBARI president and CEO, "Getting all of the components of the observatory to work together perfectly in the remote, unforgiving, inhospitable environment of the deep sea was no easy task. But the tougher the challenge, the greater the glory when it is finally achieved. Some day we may look back at the first packets of data streaming in from the MARS observatory as the equivalent of those first words spoken by Alexander Graham Bell: 'Watson, come here, I need you!'"

Like the Hubble Space Telescope, the MARS Observatory is not designed for human occupation, but is operated remotely. The observatory will serve as both a "power strip" and a "high-speed internet connection" for scientific instruments in the deep sea. It will allow marine scientists to continuously monitor the dark, mysterious world of the deep sea, instead of relying on brief oceanographic cruises and instruments that run on batteries.

The heart of observatory consists of two titanium pressure cylinders packed with computer networking and power distribution equipment. These cylinders are housed in a protective metal pyramid on the deep seafloor. This central hub is connected to shore by a 52-kilometer-long cable that can carry up to 10,000 watts of power and two gigabits per s
'/>"/>

Contact: Kim Fulton-Bennett
kfb@mbari.org
831-775-1835
Monterey Bay Aquarium Research Institute
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Scientists launch deep-sea scientific drilling program to study volatile earthquake zone
2. Deep-sea species loss could lead to oceans collapse, study suggests
3. Deep-sea sharks wired for sound
4. Persistent man-made chemical pollutants found in deep-sea octopods and squids
5. Women in Science fellowship to fund postdocs study of deep-sea methane
6. Researchers study acoustic communication in deep-sea fish

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ration is now open for the Society of Intervention...gy (IO) Therapies" Webinar, which will provide the...treatment of liver tumors, kidney tumor ablation a...tion of physicians, scientists and allied health p...through pioneering advances in image-guided therap...
(Date:11/6/2009)... generally live in harmony with their arboreal hos...ut of space in their trees of choice, the ants can...earch, published in the November issue of the Ame...nts bore into live trees, and it reopens a centuri... plants. , Ants and certain species of plants an...
(Date:11/6/2009)...mber 06, 2009) The Monell Center and the Chinese ...ing International Meeting on Taste and Smell Resea... CAS, the meeting will be the first international ... Alan Leshner, Chief Executive Officer, American ...cutive Publisher of Science magazine, will open th...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Ants are friendly to some trees, but not others 2Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 1Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 2Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 3Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 4Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 5Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 6Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 7Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 8XLHealth Appoints New Vice President of Contracting and Provider Relations 50536 1XLHealth Appoints New Vice President of Contracting and Provider Relations 50536 2Siblings target of intervention program 50533 1
...Swedish amateur boxers suggests that they have hig...inal fluid in the days following a bout, indicatin... brain function, according to a report in the Sept...AMA/Archives journals. , About 20 percent of profe...ury, according to background information in the ar...
... researchers have devised a way to use a brief bur...particles from a tiny gold launch pad. The techniq... of medicine on command from a chip implanted in t... reactions that require the controlled release of ...echnique was described Sept. 10 in a presentation ...
...s found that close to half of 154 smokers who had ...p a cigarette again within 12 months of their pot...rd were smoking at the one year mark. Sixty percen...hin two months of surgery. , The study, led by res...ne and published in the December issue of Cancer E...
Other Biology News:Amateur boxing linked to brain cell injury 2Electric jolt triggers release of biomolecules, nanoparticles 2Successful lung cancer surgery not enough to break nicotine dependence in many smokers 2Successful lung cancer surgery not enough to break nicotine dependence in many smokers 3
(Date:11/9/2009)... BEIJING, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Yo...e or "the Company") a leading manufacturer, develo... animal nutrient products in the,People,s Republic...uct a,conference call at 10:00 a.m. Eastern Time (...009 to discuss results for the quarter ended Septe...
(Date:11/9/2009)... DIEGO, Nov. 9 NexBio, Inc. announ...l American College of Allergy, Asthma, and Immunol...led "DAS181 (Fludase®), a Sialidase, Decrease...ry Effects in Animal Models of Asthma". ,, DAS1...pectrum host-targeting drug candidate being studie...
(Date:11/9/2009)... LONDON, November 9 Following the ...S Food and Drug Administration (FDA), privately,ow...//www.davalinternational.com ) has been informed t...(R) has been awarded an Orphan-Drug,designation fo...ALS). , ALS, also known as Lou Gehrig,s d...
(Date:11/6/2009)...ONTO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Bio...it has re-filed the Form 52-109F1 Certification of...tive Officer and James Long, the Chief Financial O...y 12, 2009 in connection with the annual audited f...0, 2008. ,, The Company initially filed the ann...
Breaking Biology Technology:Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3
...s, CEO of ReBuilder,Medical Technologies, Inc. (Pi... ),will be featured in an exclusive interview with...th. The interview will be posted on http://www.wa...terview will cover topics including ReBuilder Medi...initiatives, competitive,edge, recent news, and mi...
...Call/ - Quest PharmaTech Inc. (TSX,Venture Exchang...ement with,a multinational technology development ...develop oncology products based on its SonoLight T... Pharma Tech Inc. ("Quest" or the,"Company") has a...000,000,will be paid within the next twelve months...
...phagenics,Limited ("Phosphagenics") (ASX: POH, AIM...lts of its Phase 1 clinical trial that showed its,...elief drug oxycodone,through the skin without caus...results support Phosphagenics, aims to be the firs...codone patch for the management of,chronic pain., ...
Other Biology Technology:WallSt.net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies 2Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology 2Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 2Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 3
Mouse Anti-Human Actopaxin, phospho (Ser8) Monoclonal Antibody, Unconjugated, Clone J160-366 from BD Biosciences Pharmingen
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Mouse Anti-Mouse Ly 6C.2(Ly 28.2) Monoclonal Antibody, Unconjugated, Clone 5075-3.6 from CEDARLANE Laboratories Limited
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Biology Products: